FR2243M - Médicaments nouveaux, a base de dérivés naphtaléniques optiquement actifs, pour le traitement de maladies du coeur. - Google Patents

Médicaments nouveaux, a base de dérivés naphtaléniques optiquement actifs, pour le traitement de maladies du coeur.

Info

Publication number
FR2243M
FR2243M FR918704A FR918704A FR2243M FR 2243 M FR2243 M FR 2243M FR 918704 A FR918704 A FR 918704A FR 918704 A FR918704 A FR 918704A FR 2243 M FR2243 M FR 2243M
Authority
FR
France
Prior art keywords
treatment
optically active
heart disease
new drugs
naphthalene derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR918704A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to FR918704A priority Critical patent/FR2243M/fr
Application granted granted Critical
Publication of FR2243M publication Critical patent/FR2243M/fr
Priority claimed from FR99594A external-priority patent/FR1516554A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR918704A 1961-09-15 1962-12-14 Médicaments nouveaux, a base de dérivés naphtaléniques optiquement actifs, pour le traitement de maladies du coeur. Expired FR2243M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR918704A FR2243M (fr) 1961-09-15 1962-12-14 Médicaments nouveaux, a base de dérivés naphtaléniques optiquement actifs, pour le traitement de maladies du coeur.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB33157/61A GB1024643A (en) 1961-09-15 1961-09-15 Optically active naphthalene derivatives
FR918704A FR2243M (fr) 1961-09-15 1962-12-14 Médicaments nouveaux, a base de dérivés naphtaléniques optiquement actifs, pour le traitement de maladies du coeur.
FR99594A FR1516554A (fr) 1966-03-23 1967-03-21 Réacteur nucléaire à refroidissement par gaz

Publications (1)

Publication Number Publication Date
FR2243M true FR2243M (fr) 1963-12-30

Family

ID=10349278

Family Applications (1)

Application Number Title Priority Date Filing Date
FR918704A Expired FR2243M (fr) 1961-09-15 1962-12-14 Médicaments nouveaux, a base de dérivés naphtaléniques optiquement actifs, pour le traitement de maladies du coeur.

Country Status (4)

Country Link
US (1) US3312733A (fr)
CH (1) CH423810A (fr)
FR (1) FR2243M (fr)
GB (1) GB1024643A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1059968A (en) * 1964-01-20 1967-02-22 Ici Ltd Naphthalene derivatives
JPS516657B1 (fr) * 1970-08-07 1976-03-01
US4018897A (en) * 1974-07-03 1977-04-19 Eli Lilly And Company Antiarrhythmic agents
US3972935A (en) * 1974-07-03 1976-08-03 Eli Lilly And Company Antiarrhythmic agents
US4370500A (en) * 1978-11-06 1983-01-25 American Cyanamid Company Compound: d-N-(2-amino-2-phenethyl)-2-methoxyethylamine and process for preparing the same by selective crystallization
US4968837A (en) * 1989-07-28 1990-11-06 Ethyl Corporation Resolution of racemic mixtures
US5227526A (en) * 1992-06-16 1993-07-13 Mallinckrodt Specialty Chemicals Company Resolution of 3-dimethylamino-2-methylpropiophenone (3-DAMP)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2774789A (en) * 1947-10-24 1956-12-18 Sterling Drug Inc 1-arterenol and its acid-addition salts and preparation thereof
US2900415A (en) * 1954-12-14 1959-08-18 Lakeside Lab Inc Synthesized antispasmodic compounds
US2816059A (en) * 1956-03-07 1957-12-10 Lilly Co Eli N-[beta-(o-chlorophenyl)-beta-(hydroxy)-ethyl] isopropyl amine, salts thereof, and compositions containing same
US2938921A (en) * 1958-03-17 1960-05-31 Lilly Co Eli Nu-[beta-(3, 4-dichlorophenyl)-beta-hydroxyethyl] isopropylamine and salts

Also Published As

Publication number Publication date
CH423810A (de) 1966-11-15
GB1024643A (en) 1966-03-30
US3312733A (en) 1967-04-04

Similar Documents

Publication Publication Date Title
FR2427M (fr) Médicament bactériothérapique, en particulier pour le traitement d'affections gastro-intestinales.
FR2959M (fr) Nouveaux médicaments antihistaminiques a base de dérivés du thiaxanthene.
FR2243M (fr) Médicaments nouveaux, a base de dérivés naphtaléniques optiquement actifs, pour le traitement de maladies du coeur.
FR3010M (fr) Nouveaux médicaments dérivés du benzene pour le traitement des maladies cardiaques.
FR2489M (fr) Médicament pour le traitement de la dysenterie amibienne.
FR1902M (fr) Nouveaux médicaments dérivés de l'isothiazole.
FR2944M (fr) Médicament pour le traitement de la toux a base de 2-amino-6-méthylheptane.
FR3347M (fr) Médicament a activité vitaminique c a base de nouveaux 2,6-diesters d'acide ascorbique.
FR1130M (fr) Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales.
FR2253M (fr) Médicament a base de 2-(benzenesulfonyl)-amino-4-méhtyl-5-acéthylpyrimidine pour réduire le taux de la glycémie.
FR3077M (fr) Médicaments nouveaux a base de dérivés benzéniques pour le traitement de maladies des arteres coronaires.
FR3697M (fr) Médicaments a base de nouveaux composés hétérocycliques pour le traitement des maladies des arteres coronaires.
FR1843M (fr) Médicament a base d'amides d'acides 1.4-benzodioxanne-carboxyliques.
FR1967M (fr) Médicaments a base de dérivés du 1,3,4,-thiadiazole pour le traitement de l'épilepsie.
FR2576M (fr) Nouveau médicament notamment pour le traitement des troubles de la coagulabilité sanguine.
FR1242M (fr) Médicament, utilisable notamment pour le traitement des affections fongiques, a base de dérivés de la griséofulvine.
FR3153M (fr) Médicament pour le traitement des affections des coronaires, a base d'isopropylidene-2',3' adénosine.
FR2193M (fr) Nouveau médicament pour le traitement des maladies infectieuses.
FR2786M (fr) Médicament pour le traitement des maladies cardiaques.
FR3072M (fr) Nouveaux médicaments a base de dérivés des 5h-dibenzo [a,d] cycloheptenes.
FR2352M (fr) Nouveaux médicaments a base de dérivés du 5-nitrofurane.
FR1722M (fr) Médicaments nouveaux constitués par des 4-(pyridoylamido-acylamino)-1-phényl-2,3-diméthyl-pyrazolones-(5).
FI46621C (fi) Menetelmä terapeuttisesti vaikuttavien 5-fenyyli-3H-1,4-bentsodiatsepi inijohdannaisten valmistamiseksi.
FR2580M (fr) Médicament a base de guanylhydrazones de stéroides pour le traitement des insuffisances cardiaques.
FR3265M (fr) Diluant pharmaceutique.